GLP-1 & Weight Management

Semaglutide

Semaglutide — research-grade reference material, supplied in multiple sizes.

Product Code: SMG
Purity: 99%
Form: Lyophilized powder
Packaging: 5mg — Cagrilintide 2.5mg + Semaglutide 2.5mg (×10 vials)

Ships from multiple warehouses — typically 2–5 business days to nearby destinations. International orders coordinated per destination.

No prices are published. Available scope, specifications and documentation are confirmed during specification review. Supplied for research and analytical use by qualified organizations — see our Research Use Only policy.

Specification

Purity specification: 99%
Appearance: White to off-white lyophilized powder
Solubility: Reconstitutes in sterile or bacteriostatic water
Counter ion: Acetate
Form: Lyophilized Powder
Available sizes: 2mg × 10vials, 5mg × 10vials, 10mg × 10vials, 15mg × 10vials, 20mg × 10vials, 30mg × 10vials, 50mg × 10vials
Storage: Store lyophilized powder at -20°C, protected from light and moisture. After reconstitution, keep refrigerated at 2–8°C and use within the validated period.
MOQ: On request

Research Applications

Research use: semaglutide, a long-acting GLP-1 receptor agonist, is used to study glycemic-dependent insulin secretion and beta-cell function.
Weight-loss research leverages its central appetite-suppressing effects to investigate GLP-1R signaling in energy homeostasis.
Used in cardiovascular outcome studies (e.g., SELECT) to examine GLP-1-mediated effects on cardiometabolic risk.
Serves as a reference agonist in comparative pharmacology studies of incretin-based research applications for T2D and metabolic.

GLP-1 receptor agonist, the world's leading metabolic-research compound, dual effects of glycemic research and body-composition research